Biblio
Export 1190 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is D [Clear All Filters]
“Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.”, J Alzheimers Dis, vol. 54, no. 1, pp. 99-107, 2016.
, “Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1043-50, 2016.
, “Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.”, J Alzheimers Dis, vol. 63, no. 1, pp. 373-381, 2018.
, “The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1.”, J Alzheimers Dis, vol. 64, no. 1, pp. 149-169, 2018.
, “Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study.”, J Alzheimers Dis, 2015.
, “Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study.”, J Alzheimers Dis, 2015.
, “Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1267-1274, 2017.
, “Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.”, Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.
, “Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.”, Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.
, “Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.”, Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.
, “Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 71, no. 1, pp. 281-290, 2019.
, “Aerosol Delivery of Curcumin Reduced Amyloid-β Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 797-811, 2017.
, “Age and Graphomotor Decision Making Assessed with the Digital Clock Drawing Test: The Framingham Heart Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1611-1620, 2017.
, “Age and Graphomotor Decision Making Assessed with the Digital Clock Drawing Test: The Framingham Heart Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1611-1620, 2017.
, “Age of Migration and Cognitive Function Among Older Latinos in the United States.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1493-1511, 2020.
, “Age-Dependent Changes to Sphingolipid Balance in the Human Hippocampus are Gender-Specific and May Sensitize to Neurodegeneration.”, J Alzheimers Dis, 2018.
, “Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).”, J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.
, “Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).”, J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.
, “Age-Related Changes in the Synaptic Density of Amyloid-β Protein Precursor and Secretases in the Human Cerebral Cortex.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1209-14, 2016.
, “Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 529-38, 2016.
, “Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.”, J Alzheimers Dis, vol. 99, no. 3, pp. 1005-1022, 2024.
, “Alterations in the Peripheral Immune System in Dementia.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1303-1313, 2017.
, “Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.”, J Alzheimers Dis, vol. 62, no. 2, pp. 841-854, 2018.
, “Altered Affective Evaluations of Smells in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 433-41, 2016.
, “Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1477-1483, 2018.
,